| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | CD3E | Synonyms | CD3epsilon, IMD18, T3E, TCRE | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q23.3 | dbXrefs | |
| Description | CD3 epsilon subunit of T-cell receptor complex | ||||
| GTO ID | GTC3855 |
| Trial ID | NCT06373081 |
| Disease | Systemic Lupus Erythematosus | Sjogren's Syndrome | Systemic Sclerosis | Inflammatory Myopathy | Vasculitis | Antiphospholipid Syndrome |
| Altered gene | CD19|CD3E |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19/CD3E CAR-T cells |
| Phase | Not Applicable |
| Recruitment status | Recruiting |
| Title | A Clinical Study on the Safety and Efficacy of Anti-CD19-CD3E-CAR-T Cells in the Treatment of Relapsed or Refractory Autoimmune Disease |
| Year | 2024 |
| Country | China |
| Company sponsor | Shanghai Changzheng Hospital |
| Other ID(s) | CD19-CD3E-CN-A1 |
| Cohort 1 | |||||||||||
|
|||||||||||